Concepedia

Author

Kam Fai Tse

Sepragen Corporation (United States)

Also Known As

Kam Fai Tse

2

Publications

268

Citations

2

H-Index

8

Concepts

All Affiliations

Sepragen Corporation (United States)
KF

About

Kam Fai Tse is an author at Sepragen Corporation (United States) specializing in cancer cell biology, oncology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

82

2

Cell Biology

1

1

82

3

Immunology

1

1

82

4

Cancer Cell Biology

1

1

82

5

Immunotherapy

1

1

82

Kam Fai Tse

×

2

Publications

268

Citations

2

H-Index

YearCitations

CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma.

Kam Fai Tse, Michael Jeffers, Vincent A. Pollack,

Clinical Cancer Research

2006

186

Treatment parameters modulating regression of human melanoma xenografts by an antibody–drug conjugate (CR011-vcMMAE) targeting GPNMB

Vincent A. Pollack, Enrique Álvarez, Kam Fai Tse,

Cancer Chemotherapy and Pharmacology

2007

82

Page 1